Santo J. Costa's most recent trade in Aquestive Therapeutics Inc was a trade of 38,000 Stock Option (Right to Purchase) done . Disclosure was reported to the exchange on June 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Purchase) | |
| Cytokinetics Inc | Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 5,600 | 20,600 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 3,636 | 3,636 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Aquestive Therapeutics Inc | Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Cytokinetics Inc | Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 10,000 | 10,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Cytokinetics Inc | Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 5,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Santo J. Costa | Director | Sale of securities on an exchange or to another person at price $ 52.79 per share. | 01 Sep 2022 | 15,000 | 10,000 (0%) | 0% | 52.8 | 791,850 | Common Stock |
| Cytokinetics Inc | Santo J. Costa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.68 per share. | 01 Sep 2022 | 10,000 | 25,000 (0%) | 0% | 10.7 | 106,800 | Common Stock |
| Cytokinetics Inc | Santo J. Costa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 10,000 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Cytokinetics Inc | Santo J. Costa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 5,000 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Cytokinetics Inc | Santo J. Costa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 01 Sep 2022 | 5,000 | 15,000 (0%) | 0% | 9.5 | 47,250 | Common Stock |
| Aquestive Therapeutics Inc | Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Cytokinetics Inc | Santo J. Costa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.68 per share. | 02 Mar 2022 | 10,000 | 15,000 (0%) | 0% | 10.7 | 106,800 | Common Stock |
| Cytokinetics Inc | Santo J. Costa | Director | Sale of securities on an exchange or to another person at price $ 37.35 per share. | 02 Mar 2022 | 10,000 | 5,000 (0%) | 0% | 37.3 | 373,477 | Common Stock |
| Cytokinetics Inc | Santo J. Costa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 10,000 | 10,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Purchase) | |
| Cytokinetics Inc | Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 10,000 | 10,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cytokinetics Inc | Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Santo J. Costa | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 05 Oct 2020 | 15,000 | 0 (0%) | 0% | 30 | 450,000 | Common Stock |
| Cytokinetics Inc | Santo J. Costa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2020 | 15,000 | 5,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cytokinetics Inc | Santo J. Costa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 05 Oct 2020 | 15,000 | 15,000 (0%) | 0% | 9.5 | 141,750 | Common Stock |